A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents
Clinical trial NCT01424644 · COMPLETED
Trial details
- NCT number
- NCT01424644
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-12-01
- Enrollment
- 801
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.